Skip navigation

Optimize Commercial Contracting and Pricing Strategies for Product Success in an Ultra-Competitive and Evolving Healthcare System

February 27-28, 2018
  • Philadelphia, PA

Now in its fifth year, CBI’s Reimbursement and Contracting conference provides a platform for bio/pharmaceutical manufacturers looking to unravel complexities associated with reimbursement, pricing strategies and commercial contracting. As pricing pressures and competition continue to mount, reimbursement, pricing and contract teams must navigate evolving landscapes to developing competitive pricing strategies. Join experts to discuss the latest on patient access, reform, ACOs, IDNs, health insurance exchanges, Medicare Part D, 340B and much more!

Key Insights and Takeaways:

  • Identify current trends in reimbursement and contracting
  • Operationalize resources to streamline pricing/contracting structure and processes
  • Understand how pricing in various government programs is impacted by the evolving complexity of managed market contracts
  • Align pricing projections with payer coverage while maintaining patient affordability
  • Discuss the role of the 340B program and its impact on prescription drug prices
  • Explore market trends in specialty products and biosimilars to develop contracts for long-term success
  • Gain strategies for properly linking discounts and rebates with value and outcomes

PREVIOUS ATTENDEE ACCLAIM:

Excellent conference to bring the commercial and government contracting perspectives together.

Department Director, Government Contracts and Reporting, Bayer

Extremely well run conference where ideas were shareed so everyone could benefit and learn from the group!

Business Relations Manager, Sanofi Genzyme

The in-depth introduction of pros and cons for outcomes-based contracting opened the door for exploration.

Senior Business Partner, Indivior

February 27-28, 2018 Philadelphia, PA

Reimbursement and Contracting 2018

Optimize Commercial Contracting and Pricing Strategies for Product Success in an Ultra-Competitive and Evolving Healthcare System

Now in its fifth year, CBI’s Reimbursement and Contracting conference provides a platform for bio/pharmaceutical manufacturers looking to unravel complexities associated with reimbursement, pricing strategies and commercial contracting. As pricing pressures and competition continue to mount, reimbursement, pricing and contract teams must navigate evolving landscapes to developing competitive pricing strategies. Join experts to discuss the latest on patient access, reform, ACOs, IDNs, health insurance exchanges, Medicare Part D, 340B and much more!

Key Insights and Takeaways:

  • Identify current trends in reimbursement and contracting
  • Operationalize resources to streamline pricing/contracting structure and processes
  • Understand how pricing in various government programs is impacted by the evolving complexity of managed market contracts
  • Align pricing projections with payer coverage while maintaining patient affordability
  • Discuss the role of the 340B program and its impact on prescription drug prices
  • Explore market trends in specialty products and biosimilars to develop contracts for long-term success
  • Gain strategies for properly linking discounts and rebates with value and outcomes

PREVIOUS ATTENDEE ACCLAIM:

Excellent conference to bring the commercial and government contracting perspectives together.

Department Director, Government Contracts and Reporting, Bayer

Extremely well run conference where ideas were shareed so everyone could benefit and learn from the group!

Business Relations Manager, Sanofi Genzyme

The in-depth introduction of pros and cons for outcomes-based contracting opened the door for exploration.

Senior Business Partner, Indivior

February 27-28, 2018 Philadelphia, PA